GPI (+) cells from PNH patients had worse growth compared to GPI (-) cells and compared to CD34+ cells from controls, accompanied by higher expression of CD95 (Fas receptor) and higher sensitivity to Fas antibody treatment. This evidence concerns the gene FAS and paroxysmal nocturnal hemoglobinuria.